Mesoblast Ltd (MESO): Secure Exclusive Rights to a Vital Platform [Yahoo! Finance]
Mesoblast Limited - American Depositary Shares (MESO)
US:NASDAQ Investor Relations:
investorsmedia.mesoblast.com
Company Research
Source: Yahoo! Finance
secured exclusive global rights to a patented technology platform from Mayo Clinic. This platform uses chimeric antigen receptors, and it helps improve the performance of mesenchymal lineage stromal cell (MSC) therapeutic products. Mesoblast Ltd (MESO): Secure Exclusive Rights to a Vital Platform Source:unsplash The company said the platform is designed to help mesenchymal stromal cells to better locate and act on inflamed tissue. Mesoblast plans to use the technology to sharpen the ability of its therapies to more precisely and effectively target areas of disease, increase immune response, and support tissue regeneration. With this platform, Mesoblast sees an opportunity to generate therapies for diseases such as ulcerative colitis and Crohn's disease. Moreover, the company sees potential for therapies for other immune disorders with the CAR technology platform in its grasp. The CAR technology platform was developed by scientists at Mayo Clinic, and the license was held by
Show less
Read more
Impact Snapshot
Event Time:
MESO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MESO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MESO alerts
High impacting Mesoblast Limited - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
MESO
News
- Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back PainGlobeNewswire
- Why Mesoblast Limited (MESO) is One of the Best Low Priced Biotech Stocks to Invest in [Yahoo! Finance]Yahoo! Finance
- Mesoblast Limited (MESO), One of the Best Long-Term ASX Stocks To Buy Right Now; See Why [Yahoo! Finance]Yahoo! Finance
- Mesoblast Acquires Chimeric Antigen Receptor (CAR) Platform Technology for Precision-Enhanced Cell ProductsGlobeNewswire
- ASX April 2026 Stocks Estimated To Be Trading Below Fair Value [Yahoo! Finance]Yahoo! Finance
MESO
Sec Filings
- 4/29/26 - Form 3
- 4/13/26 - Form 4
- 4/10/26 - Form 4
- MESO's page on the SEC website